World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

PHARMACOVIGILANCE STUDY ON PROTON PUMP INHIBITORS IN ACUTE MEDICAL WARD AT CIVIL HOSPITAL

Mattapalli Srinayani* and Parankusham Vindhya

ABSTRACT

Proton Pump Inhibitors (PPIs) are mostly used in almost all the cases due to patients may suffer with hospital induced excess acid, Medication induced acid production or Disease itself causing excess acid production. These Proton Pump Inhibitors help in reducing the excess acid production by blocking the H, K-ATPase. But, these drugs though they have good safety profile they may also cause few Adverse Drug Reactions (ADR’s). So, we have conducted a Prospective Observational study for a period of one year and found 152 ADR’s related to PPIs and found mostly prescribed drug among PPIs is Pantoprazole (51%) followed by Omeprazole (34%). Most common ADR found was Urticaria (36.2%) followed by angioedema (21.8%). We have done the severity and preventability assessment and found that most of the ADRs are Mild (51.3%) and Probably Preventable (63%). Based on all these findings we can conclude that Hypersensitivity reactions are commonly occurring due to PPIs. So, Proper monitoring in the initial stage of therapy can reduce the suffering of the patient.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR